Literature DB >> 21676482

Healthcare access and burden of care for patients with Lyme disease: a large United States survey.

Lorraine Johnson1, Alexandra Aylward, Raphael B Stricker.   

Abstract

OBJECTIVE: To evaluate the challenges faced by Lyme disease patients in obtaining adequate healthcare.
METHODS: A web-based survey conducted over nine months was analyzed for the study. The survey focused on medical status, access to healthcare, and burden of illness. For inclusion in the study, survey respondents had to reside in the United States, be more than 10 years old, and have clinically diagnosed Lyme disease with chronic symptoms and positive laboratory testing.
RESULTS: Responses from 2424 patients were included in the study. Half of the respondents reported seeing at least seven physicians before the diagnosis of Lyme disease was made. Nearly half had Lyme disease for more than 10 years and traveled over 50 miles to obtain treatment. Most respondents experienced symptoms lasting six months or more despite receiving at least 21 days of antibiotic treatment. A quarter of respondents had been on public support or received disability benefits due to Lyme disease symptoms, and over half had visited an emergency room at least once as a result of these symptoms.
CONCLUSIONS: Lyme disease patients frequently endure extensive delays in obtaining an initial diagnosis, have poor access to healthcare and suffer a severe burden of illness.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21676482     DOI: 10.1016/j.healthpol.2011.05.007

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  23 in total

Review 1.  Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease.

Authors:  Daniel J Cameron; Lorraine B Johnson; Elizabeth L Maloney
Journal:  Expert Rev Anti Infect Ther       Date:  2014-07-30       Impact factor: 5.091

2.  Impact of prior and projected climate change on US Lyme disease incidence.

Authors:  Lisa I Couper; Andrew J MacDonald; Erin A Mordecai
Journal:  Glob Chang Biol       Date:  2020-11-22       Impact factor: 10.863

Review 3.  Lyme disease: call for a "Manhattan Project" to combat the epidemic.

Authors:  Raphael B Stricker; Lorraine Johnson
Journal:  PLoS Pathog       Date:  2014-01-02       Impact factor: 6.823

Review 4.  Relevance of chronic lyme disease to family medicine as a complex multidimensional chronic disease construct: a systematic review.

Authors:  Liesbeth Borgermans; Geert Goderis; Jan Vandevoorde; Dirk Devroey
Journal:  Int J Family Med       Date:  2014-11-24

5.  Health care costs, utilization and patterns of care following Lyme disease.

Authors:  Emily R Adrion; John Aucott; Klaus W Lemke; Jonathan P Weiner
Journal:  PLoS One       Date:  2015-02-04       Impact factor: 3.240

6.  The first evidence of lyme neuroborreliosis in southern bosnia and herzegovina.

Authors:  Jurica Arapovic; Sinisa Skocibusic; Svjetlana Grgic; Jadranka Nikolic
Journal:  Case Rep Infect Dis       Date:  2014-12-15

7.  Severity of chronic Lyme disease compared to other chronic conditions: a quality of life survey.

Authors:  Lorraine Johnson; Spencer Wilcox; Jennifer Mankoff; Raphael B Stricker
Journal:  PeerJ       Date:  2014-03-27       Impact factor: 2.984

8.  Experiences of patients identifying with chronic Lyme disease in the healthcare system: a qualitative study.

Authors:  Ather Ali; Lawrence Vitulano; Robert Lee; Theresa R Weiss; Eve R Colson
Journal:  BMC Fam Pract       Date:  2014-05-01       Impact factor: 2.497

9.  Lyme disease: the promise of Big Data, companion diagnostics and precision medicine.

Authors:  Raphael B Stricker; Lorraine Johnson
Journal:  Infect Drug Resist       Date:  2016-09-13       Impact factor: 4.003

10.  Controversies in Persistent (Chronic) Lyme Disease.

Authors:  Elizabeth L Maloney
Journal:  J Infus Nurs       Date:  2016 Nov/Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.